While abnormal metabolism of Aβ and Tau proteins are hallmarks of AD and the most trusted identifiers and predictors of AD, a recent paradigm shift has occurred that emphasizes the initial and central role of AβO in AD pathogenesis [11]. The gene discussed is MAPT; the disease is Alzheimer disease.